Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Novartis to Use Mobile Technology in Up to 10 Clinical Trials

Wednesday, March 7, 2018   (0 Comments)
Share |



Reuters reports that Novartis (NYSE:NVS) plans to use mobile technology developed by Los Angeles, CA-based Science 37 in as many as 10 clinical trials over the next three years. The company says it will employ Science's smartphone apps alloying study participants to use video-based telemedicine instead of having to physically visit clinics, a major deterrent in patient recruitment.

Novartis owns 10% of Science 37 on the basis of a $29M financing round last April with other investors, including Sanofi (NYSE:SNY) and Amgen (NASDAQ:AMGN).

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal